Literature DB >> 24573903

Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease.

Karen Nuytemans1, Vanessa Inchausti, Gary W Beecham, Liyong Wang, Dennis W Dickson, John Q Trojanowski, Virginia M-Y Lee, Deborah C Mash, Matthew P Frosch, Tatiana M Foroud, Lawrence S Honig, Thomas J Montine, Ted M Dawson, Eden R Martin, William K Scott, Jeffery M Vance.   

Abstract

BACKGROUND: We have reported that intermediate repeat lengths of the C9ORF72 repeat are a risk factor for Parkinson's disease (PD) in a clinically diagnosed data set. Because 10% to 25% of clinically diagnosed PD have different diagnoses upon autopsy, we hypothesized that this may reflect phenotypic heterogeneity or concomitant pathology of other neurodegenerative disorders.
METHODS: We screened 488 autopsy-confirmed PD cases for expansion haplotype tag rs3849942T. In 196 identified haplotype carriers, the C9ORF72 repeat was genotyped using the repeat-primed polymerase chain reaction assay.
RESULTS: No larger (intermediate or expanded) repeats were found in these autopsy-confirmed PD samples. This absence of larger repeats is significantly different from the frequency in clinically diagnosed datasets (P = 0.002).
CONCLUSIONS: Our results suggest that expanded or intermediate C9ORF72 repeats in clinically diagnosed PD or parkinsonism might be an indication of heterogeneity in clinically diagnosed PD cases. Further studies are needed to elucidate the potential contribution of the C9ORF72 repeat to autopsy-confirmed PD.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  C9ORF72 repeat; Parkinson's disease; autopsy confirmed; parkinsonism

Mesh:

Substances:

Year:  2014        PMID: 24573903      PMCID: PMC4022044          DOI: 10.1002/mds.25838

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  38 in total

1.  Ecology of the aging human brain.

Authors:  Joshua A Sonnen; Karen Santa Cruz; Laura S Hemmy; Randall Woltjer; James B Leverenz; Kathleen S Montine; Clifford R Jack; Jeffrey Kaye; Kelvin Lim; Eric B Larson; Lon White; Thomas J Montine
Journal:  Arch Neurol       Date:  2011-08

2.  Investigation of C9orf72 repeat expansions in Parkinson's disease.

Authors:  Hussein Daoud; Anne Noreau; Daniel Rochefort; Gabriel Paquin-Lanthier; Maude Turcotte Gauthier; Pierre Provencher; Emmanuelle Pourcher; Nicolas Dupré; Sylvain Chouinard; Nicolas Jodoin; Valérie Soland; Edward A Fon; Patrick A Dion; Guy A Rouleau
Journal:  Neurobiol Aging       Date:  2012-12-27       Impact factor: 4.673

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.

Authors:  Stéphanie Millecamps; Séverine Boillée; Isabelle Le Ber; Danielle Seilhean; Elisa Teyssou; Marine Giraudeau; Carine Moigneu; Nadia Vandenberghe; Véronique Danel-Brunaud; Philippe Corcia; Pierre-François Pradat; Nadine Le Forestier; Lucette Lacomblez; Gaelle Bruneteau; William Camu; Alexis Brice; Cécile Cazeneuve; Eric Leguern; Vincent Meininger; François Salachas
Journal:  J Med Genet       Date:  2012-04       Impact factor: 6.318

5.  Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease.

Authors:  S G Lindquist; M Duno; M Batbayli; A Puschmann; H Braendgaard; S Mardosiene; K Svenstrup; L H Pinborg; K Vestergaard; L E Hjermind; J Stokholm; B B Andersen; P Johannsen; J E Nielsen
Journal:  Clin Genet       Date:  2012-07-04       Impact factor: 4.438

6.  C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment.

Authors:  Rita Cacace; Caroline Van Cauwenberghe; Karolien Bettens; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Mathieu Vandenbulcke; Jasper Van Dongen; Veerle Bäumer; Lubina Dillen; Maria Mattheijssens; Karin Peeters; Marc Cruts; Rik Vandenberghe; Peter P De Deyn; Christine Van Broeckhoven; Kristel Sleegers
Journal:  Neurobiol Aging       Date:  2013-01-24       Impact factor: 4.673

7.  Parkinson disease is not associated with C9ORF72 repeat expansions.

Authors:  Matthew B Harms; Drexel Neumann; Bruno A Benitez; Breanna Cooper; David Carrell; Brad A Racette; Joel S Perlmutter; Alison Goate; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2012-10-30       Impact factor: 4.673

8.  C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study.

Authors:  Johnathan Cooper-Knock; Antonina Frolov; J Robin Highley; Gavin Charlesworth; Janine Kirby; Antonio Milano; Judith Hartley; Paul G Ince; Christopher J McDermott; Tammaryn Lashley; Tamas Revesz; Pamela J Shaw; Nicholas W Wood; Oliver Bandmann
Journal:  Neurology       Date:  2013-07-24       Impact factor: 9.910

9.  Repeat expansion in C9ORF72 in Alzheimer's disease.

Authors:  Elisa Majounie; Yevgeniya Abramzon; Alan E Renton; Rodney Perry; Susan S Bassett; Olga Pletnikova; Juan C Troncoso; John Hardy; Andrew B Singleton; Bryan J Traynor
Journal:  N Engl J Med       Date:  2012-01-04       Impact factor: 91.245

10.  Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.

Authors:  Johnathan Cooper-Knock; Christopher Hewitt; J Robin Highley; Alice Brockington; Antonio Milano; Somai Man; Joanne Martindale; Judith Hartley; Theresa Walsh; Catherine Gelsthorpe; Lynne Baxter; Gillian Forster; Melanie Fox; Joanna Bury; Kin Mok; Christopher J McDermott; Bryan J Traynor; Janine Kirby; Stephen B Wharton; Paul G Ince; John Hardy; Pamela J Shaw
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

View more
  12 in total

1.  C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.

Authors:  Antonino Cannas; Paolo Solla; Giuseppe Borghero; Gian Luca Floris; Adriano Chio; Marcello Mario Mascia; Nicola Modugno; Antonella Muroni; Gianni Orofino; Francesca Di Stefano; Andrea Calvo; Cristina Moglia; Gabriella Restagno; Mario Meloni; Rita Farris; Daniela Ciaccio; Roberta Puddu; Melisa Iris Vacca; Rosanna Melis; Maria Rita Murru; Stefania Tranquilli; Daniela Corongiu; Marcella Rolesu; Stefania Cuccu; Maria Giovanna Marrosu; Francesco Marrosu
Journal:  J Neurol       Date:  2015-08-15       Impact factor: 4.849

2.  C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy.

Authors:  Christopher P Cali; Maribel Patino; Yee Kit Tai; Wan Yun Ho; Catriona A McLean; Christopher M Morris; William W Seeley; Bruce L Miller; Carles Gaig; Jean Paul G Vonsattel; Charles L White; Sigrun Roeber; Hans Kretzschmar; Juan C Troncoso; Claire Troakes; Marla Gearing; Bernardino Ghetti; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Kin Y Mok; Helen Ling; Dennis W Dickson; Gerard D Schellenberg; Shuo-Chien Ling; Edward B Lee
Journal:  Acta Neuropathol       Date:  2019-07-20       Impact factor: 17.088

3.  C9ORF72 repeat expansions in Chinese patients with Parkinson's disease and multiple system atrophy.

Authors:  Xueping Chen; Yongping Chen; Qianqian Wei; Ruwei Ou; Bei Cao; Bi Zhao; Hui-Fang Shang
Journal:  J Neural Transm (Vienna)       Date:  2016-07-29       Impact factor: 3.575

4.  Differences in Motor Features of C9orf72, MAPT, or GRN Variant Carriers With Familial Frontotemporal Lobar Degeneration.

Authors:  Philip Wade Tipton; Angela B Deutschlaender; Rodolfo Savica; Michael G Heckman; Danielle E Brushaber; Bradford C Dickerson; Ralitza H Gavrilova; Daniel H Geschwind; Nupur Ghoshal; Jonathan Graff-Radford; Neill R Graff-Radford; Murray Grossman; Ging-Yuek R Hsiung; Edward D Huey; David John Irwin; David T Jones; David S Knopman; Scott M McGinnis; Rosa Rademakers; Eliana Marisa Ramos; Leah K Forsberg; Hilary W Heuer; Chiadi Onyike; Carmela Tartaglia; Kimiko Domoto-Reilly; Erik D Roberson; Mario F Mendez; Irene Litvan; Brian S Appleby; Ian Grant; Daniel Kaufer; Adam L Boxer; Howard J Rosen; Brad F Boeve; Zbigniew K Wszolek
Journal:  Neurology       Date:  2022-07-05       Impact factor: 11.800

Review 5.  C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature.

Authors:  Thomas Bourinaris; Henry Houlden
Journal:  Mov Disord Clin Pract       Date:  2018-11-08

6.  Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond.

Authors:  Dario Saracino; Isabelle Le Ber
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.

Authors:  Thomas J Montine; Kathleen S Montine
Journal:  J Exp Med       Date:  2015-05-04       Impact factor: 14.307

8.  Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.

Authors:  Jessie Theuns; Aline Verstraeten; Kristel Sleegers; Eline Wauters; Ilse Gijselinck; Stefanie Smolders; David Crosiers; Ellen Corsmit; Ellen Elinck; Manu Sharma; Rejko Krüger; Suzanne Lesage; Alexis Brice; Sun Ju Chung; Mi-Jung Kim; Young Jin Kim; Owen A Ross; Zbigniew K Wszolek; Ekaterina Rogaeva; Zhengrui Xi; Anthony E Lang; Christine Klein; Anne Weissbach; George D Mellick; Peter A Silburn; Georgios M Hadjigeorgiou; Efthimios Dardiotis; Nobutaka Hattori; Kotaro Ogaki; Eng-King Tan; Yi Zhao; Jan Aasly; Enza Maria Valente; Simona Petrucci; Grazia Annesi; Aldo Quattrone; Carlo Ferrarese; Laura Brighina; Angela Deutschländer; Andreas Puschmann; Christer Nilsson; Gaëtan Garraux; Mark S LeDoux; Ronald F Pfeiffer; Magdalena Boczarska-Jedynak; Grzegorz Opala; Demetrius M Maraganore; Sebastiaan Engelborghs; Peter Paul De Deyn; Patrick Cras; Marc Cruts; Christine Van Broeckhoven
Journal:  Neurology       Date:  2014-10-17       Impact factor: 9.910

Review 9.  Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.

Authors:  Carmen Gasca-Salas; Mario Masellis; Edwin Khoo; Binit B Shah; David Fisman; Anthony E Lang; Galit Kleiner-Fisman
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

10.  Analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism.

Authors:  Lucia V Schottlaender; James M Polke; Helen Ling; Nicola D MacDoanld; Arianna Tucci; Tina Nanji; Alan Pittman; Rohan de Silva; Janice L Holton; Tamas Revesz; Mary G Sweeney; Andy B Singleton; Andrew J Lees; Kailash P Bhatia; Henry Houlden
Journal:  Neurobiol Aging       Date:  2014-08-27       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.